Skip to content

Pharmacy based screening of high risk individuals using stepwise methods

Pharmacy based screening of high Risk Individuals using Stepwise Methods: the PRISM study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10605140
Enrollment
2406
Registered
2014-02-20
Start date
2011-03-01
Completion date
Unknown
Last updated
2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early detection of type 2 diabetes Nutritional, Metabolic, Endocrine Non-insulin-dependent diabetes mellitus

Interventions

Participants will be individually block randomised to one of two screening arms Trial arm 1. Near patient test A paper based version of the Leicester Self-Assessment (

Sponsors

University of Leicester (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 40-75 years old (35 to 75 if South Asian due to the increased diabetes risk)

Exclusion criteria

Exclusion criteria: 1. Already diagnosed with diabetes 2. Have had a fasting test for diabetes in the previous 12 months performed elsewhere 3. Have a mental impairment, learning difficulty or chronic disease which may impair ability to give informed consent

Design outcomes

Primary

MeasureTime frame
Percentage uptake of high risk individuals by a pharmacy test to a confirmatory test at the GP surgery Primary and secondary outcome data will be extracted via a query of participants medical records by a member of the study team. This will be completed at 3 months post screening appointment.

Secondary

MeasureTime frame
Number of participants diagnosed with type 2 diabetes and impaired glucose regulation according to the final confirmatory test at the GP surgery

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026